Blai Coll

Blai Coll has a diverse work experience in the medical field. Blai currently holds the position of VP Endocrine and Metabolism Clinical Development at Structure Therapeutics. Prior to this, they worked at Amgen, where they served as the Cardiovascular and Metabolic Platform Lead in Medical Affairs. Blai also held the roles of US Medical Lead for Repatha, Medical Director for Global Medical Affairs Cardiovascular, and Clinical Research Medical Director for Amgen Cardiovascular. Before joining Amgen, Blai worked as a Medical Director at AbbVie. Blai started their career as an Internal Medicine Fellow at Hospital Sant Joan, Reus. Additionally, Blai has experience as a Director at UDETMA, a clinical research organization focusing on cardiovascular prevention. Blai also served as a Clinical Research Fellow at Instituto de Salud Carlos III and Hospital Sant Joan, where they conducted basic research in the Atherosclerosis Research Laboratory.

Blai Coll has a strong educational background in the field of Medicine. Blai obtained their Medical doctor degree from the Universitat Autonoma de Barcelona School of Medicine from 1991 to 1997. Blai further specialized in Internal Medicine from 1998 to 2003. Later, Blai pursued a PhD in Medicine from 2004 to 2007 at Universitat Rovira i Virgili. Additionally, they have also pursued a PhD in Internal Medicine at an unspecified time.